IBC’s Sixth Annual BMD Summit Biopharmaceutical Manufacturing and Development Streamline Facility and Capacity Management, Minimize Downtime, and Mitigate Raw Material Risk

View PDF



The BMD Summit comprises two in-depth tracks, a combination of programming that will help you increase your manufacturing agility, reduce process variability, and achieve your manufacturing and development goals.

Tracks and Session Topics

Preconference Workshop: “Mitigating the Risk and Impact of Viral Contaminations: Technical Aspects” (new this year)

Track #1, Enabling Efficient Facilities: This track provides you with insights on how to achieve scale and product flexibility. You will hear perspectives from major biopharmaceutical companies on when and where to implement disposables — and the latest novel downstream technologies that can help you improve your plant’s flexibility and efficiency.

A plenary session on critical industry updates includes Genzyme’s adventitious agent control, Biocon’s economic strategies, Baxter’s inventory tips, and Pfizer’s operational excellence practices. Other sessions address

  • Building scale and product flexibility into existing and new facilities

  • Evaluating and implementing disposables

  • Novel downstream technologies for improved flexibility and efficiency.

COLOCATED CONFERENCE

Preclinical Scale Bioprocessing provides the strategies you need to navigate this critical stage of bioprocess development while conserving resources, optimizing product quality, and supporting a successful IND filing.www.IBCLifeSciences.com/preclinical

Track #2, Manufacturing Excellence: Enhance your company’s continuous improvement initiatives by seeing how industry leaders manage their inventory strategy, materials clearance programs, and manufacturing organizational and operational excellence strategies — and how they use modeling tools for resource management.

After the shared plenary session with Track #1, other manufacturing excellence sessions address

  • Managing risk in the increasingly complex supply chain

  • Managing a business with tighter resources and higher demand

  • Risk management approaches to process design and manufacturing flexibility.

Don’t-Miss Presentations

“Inventory: Asset or Evil” by William Botha (Irvine specialty therapies facility plant manager for Baxter Bioscience)

“Economics of Biologics Manufacturing and Novel Strategies for Cost Optimization” by Srinivasan Raman (general manager of operations in biologics manufacturing for Biocon in India)

Featured Presentation: “Adventitious Agent Detection and Prevention” by Nathan Jones, PhD (senior scientist in purification process research for Genzyme Corporation)

Keynote: “The Changing Face of Biopharmaceutical Manufacturing” by Rick Pierro (president and CEO of Superior Controls)

Attendee Profile

Scientists and engineers in process development, process engineering, and manufacturing sciences who are tasked with developing flexible facilities, ensuring safety of raw materials and quality of product, and implementing continuous improvement initatives will benefit from this conference.

Hear what your peers have to say:

“This will be a great opportunity to learn what other specialists are doing in the disposables for biotech arena.”

— James W. Chrostowski, PhD (engineer III at Biogen Idec)

“IBC conferences provide a platform to understand/gauge the best practices of the industry, thus a great opportunity to benchmark oneself! I look forward to being a part of BMD Summit 2010.”

— Srinivasan Raman (general operations manager for biologics manufacturing at Biocon in India)

“Greatly facilitates keeping informed of current key biotech practices, learnings, and players/SMEs” — Stacey M. Kaneshiro (senior consultant engineer for Eli Lilly and Company)



Early registration is encouraged to take advantage of preregistration discounts. Group discounts are also available to groups of three or more attendees. Complete details can be found on the website, or call 1-800-309-4078. When registering, mention priority code BMDBPIFE.

Leave a Reply